Walleye Capital LLC Purchases New Position in Avanos Medical, Inc. $AVNS

Key Points

• Walleye Capital LLC has acquired a new position in Avanos Medical, purchasing 65,603 shares valued at approximately $940,000, which accounts for about 0.14% of the company.
• Avanos Medical's shares recently increased by 0.5%, with a current trading price of $11.93 and a market cap of $553.74 million.
• Following the company's latest quarterly earnings report, Avanos Medical missed the consensus earnings per share estimate, reporting $0.17 EPS against an expected $0.18.

Walleye Capital LLC purchased a new stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 65,603 shares of the company's stock, valued at approximately $940,000. Walleye Capital LLC owned about 0.14% of Avanos Medical at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. State of Wyoming lifted its holdings in shares of Avanos Medical by 132.0% in the 4th quarter. State of Wyoming now owns 5,137 shares of the company's stock valued at $82,000 after acquiring an additional 2,923 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Avanos Medical by 493.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock valued at $129,000 after acquiring an additional 6,714 shares during the last quarter. EP Wealth Advisors LLC lifted its holdings in shares of Avanos Medical by 14.6% in the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock valued at $161,000 after acquiring an additional 1,289 shares during the last quarter. Heritage Family Offices LLP bought a new position in shares of Avanos Medical in the 1st quarter valued at about $146,000. Finally, Mariner LLC lifted its holdings in shares of Avanos Medical by 18.0% in the 4th quarter. Mariner LLC now owns 10,655 shares of the company's stock valued at $170,000 after acquiring an additional 1,625 shares during the last quarter. Institutional investors own 95.17% of the company's stock.

Avanos Medical Stock Up 0.5%

Shares of NYSE AVNS opened at $11.93 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.64 and a quick ratio of 1.58. The company has a market cap of $553.74 million, a P/E ratio of -1.19 and a beta of 1.12. Avanos Medical, Inc. has a 1 year low of $9.30 and a 1 year high of $25.36. The firm has a 50-day simple moving average of $11.62 and a two-hundred day simple moving average of $12.82.

Avanos Medical (NYSE:AVNS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Avanos Medical had a positive return on equity of 6.16% and a negative net margin of 66.89%.The firm had revenue of $175.00 million during the quarter, compared to the consensus estimate of $165.50 million. During the same period in the previous year, the business earned $0.34 EPS. Avanos Medical has set its FY 2025 guidance at 0.750-0.950 EPS. Research analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Insider Buying and Selling at Avanos Medical

In related news, Director Gary Blackford purchased 40,000 shares of the firm's stock in a transaction dated Wednesday, August 13th. The stock was purchased at an average price of $10.99 per share, with a total value of $439,600.00. Following the completion of the purchase, the director owned 40,000 shares of the company's stock, valued at approximately $439,600. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.64% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently commented on AVNS. Wall Street Zen downgraded shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Zacks Research raised shares of Avanos Medical to a "hold" rating in a research note on Tuesday, August 12th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of "Hold".

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.